Recently, the "Yi Screening" project jointly organized by Beijing Temple of Heaven Puhua Hospital and Dr. Zhang Qinyi Group was officially launched in Beijing Temple of Heaven Puhua Hospital, bringing together experts, scholars and industry insiders in the medical field to jointly improve the current situation and challenges of cardiovascular and cerebrovascular disease prevention and treatment.
Yu Qiang, Executive Vice President of Beijing Temple of Heaven Puhua Hospital, Han Cuijie, Vice President of Beijing Temple of Heaven Puhua Hospital, and heads of relevant departments, Professor Zhang Qinyi, founder of Dr. Zhang Qinyi Group, members of the team expert group and other special guests attended the kick-off meeting
Mr. Yu Qiang, Executive Vice President of Beijing Temple of Heaven Puhua Hospital, first expressed his gratitude to the guests for coming. He said that the hospital has been committed to the prevention and treatment of cardiovascular and cerebrovascular diseases, and hopes that through this cooperation, we can jointly explore more effective diagnosis and treatment plans and provide patients with better medical services.
President Yu Qiang delivered a speech.
Ms. Han Cuijie, Vice President of Beijing Temple of Heaven Puhua Hospital, introduced the achievements of Beijing Temple of Heaven Puhua Hospital in the construction and development of disciplines. She said that the hospital has first-class medical facilities and advanced technological equipment, which provides a safe and comfortable environment for patients. At the same time, Tiantan Puhua Hospital pays attention to the application of advanced medical technology and actively promotes the innovation and development of medical technology to meet the diverse needs of patients.
Dean Han Cuijie delivered a speech.
Zhang Qinyi, founder and professor of Dr. Zhang Qinyi Group, gave a detailed introduction to the "Yi Screening" project. He said that "Yi Screening" is a comprehensive system based on the concept and means of lifeline screening, integrating artificial intelligence, blockchain, cloud technology, big data and other multiple science and technology, which constitute the core competitiveness of "Yi Screening". The goal of "Yi Screening" is to use the most cutting-edge medical technology and research results to achieve early screening and accurate diagnosis of cardiovascular and cerebrovascular diseases. 
Professor Zhang Qinyi delivered a speech.
After the launching ceremony, Professor Zhang Qinyi and Dean Han Cuijie also accepted an interview. Professor Zhang Qinyi introduced that in terms of technology application and innovation, the "Yi Screening" project has a number of breakthroughs and highlights - through the monitoring of risk factors, combined with big data and artificial intelligence and other technical means, to improve the early detection and intervention of cardiovascular and cerebrovascular diseases;At the same time, it emphasizes the importance of preventing sudden death, cerebral infarction and myocardial infarction, and reduces the incidence of cardiovascular and cerebrovascular diseases through timely detection and risk factors.
Ms. Han Cuijie, Vice President of Tiantan Puhua Hospital, answered questions from reporters on the future cooperation plan between the two sides. She mentioned that in the future, the two sides will deepen cooperation to create a full chain of medical services, including prevention, diagnosis and treatment, health management and other aspectsDean Han Cuijie also said that through big data statistics and research, we can better understand the prevention and treatment of cardiovascular and cerebrovascular diseases, and provide a lot of support for academic research in related fields in the future. At the same time, she also looks forward to sharing the medical data and research results of the Chinese population on the stage of international medical magazines, so that more people can understand the progress of China's medical industry.
This event is a good opportunity for the two sides to deepen cooperation and seek common development. The two parties will cooperate to achieve complementarity and innovation in cardiovascular and cerebrovascular health management, jointly formulate more reliable and effective cardiovascular and cerebrovascular disease screening and prevention programs, and provide the public with better quality, comprehensive and thoughtful medical services. At the same time, we also welcome more medical professionals who pay attention to cardiovascular and cerebrovascular health to join us and contribute to the construction of a healthy China.